Skip to main content

Table 2 Factors associated with exposure to the main intervention components: Assessment of lifestyle (A1), and prescription of lifestyle change (A4)

From: Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial

Variables

Adjusted hazard ratio (95% CI)

Assessed (A1)

Prescribed (A4)

Age in years

≥ 75

1.00

1.00

 

30-54

3.14 (2.21-4.47)

3.33 (1.97-5.64)

 

55-64

4.64 (3.40-6.33)

5.76 (3.63-9.12)

 

65-75

3.96 (2.91-5.40)

4.51 (2.85-7.14)

Sex

Female

1.00

1.00

Male

0.90 (0.75-1.08)

0.85 (0.66-1.09)

Chol > 240

No

1.00

1.00

Yes

0.71 (0.55-0.92)

0.69 (0.45-0.99)

DBP > 90

No

1.00

1.00

Yes

0.69 (0.52-0.92)

0.77 (0.53-1.13)

BMI ≥ 30

No

1.00

1.00

Yes

1.28 (1.07-1.54)

1.35 (1.05-1.74)

Group

Global

1.00

1.00

0-8 months

Sequential

0.98 (0.79-1.20)

1.02 (0.76-1.36)

9-12 months

Sequential

2.61 (1.77-3.83)

2.33 (1.38-3.94)

  1. Note: BMI, body mass index in kg/m2; Chol, cholesterol level in mg/dL; DBP, diastolic blood pressure in mmHg